ChromaDex to Present at the 5th Annual B. Riley FBR Consumer and Media Conference
September 26, 2019 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, Sept. 26, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will present at...
ChromaDex Announces $7 Million Private Placement of Common Stock
August 14, 2019 09:10 ET
|
ChromaDex Corporation
LOS ANGELES, Aug. 14, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it has entered into a securities purchase agreement for the sale of $7.0 million of its common stock...
ChromaDex Receives Positive Opinion on Nicotinamide Riboside as a Novel Food from the World-Leading European Food Safety Authority (EFSA)
August 07, 2019 16:10 ET
|
ChromaDex Corporation
LOS ANGELES, Aug. 07, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today announced that the European Food Safety Authority (EFSA) has issued a positive opinion on Nicotinamide Riboside...
ChromaDex Corporation Reports Second Quarter 2019 Financial Results
August 07, 2019 16:01 ET
|
ChromaDex Corporation
Second Quarter 2019 Highlights vs. Second Quarter 2018 Strong growth in net sales to $11.1 million, significantly higher gross margins, and improved marketing efficiency year-over-yearTRU...
ChromaDex Adds Top Talent to its Leadership Team
August 06, 2019 16:05 ET
|
ChromaDex Corporation
LOS ANGELES, Aug. 06, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today three...
ChromaDex to Report Second Quarter 2019 Financial Results on Wednesday, August 7, 2019
July 31, 2019 16:05 ET
|
ChromaDex Corporation
LOS ANGELES, July 31, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed., August 7, 2019 at 4:30 p.m. Eastern time to discuss its financial...
TRU NIAGEN® Expands Canadian Retail Footprint with Distribution at Whole Foods Ontario Locations
July 24, 2019 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, July 24, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today its flagship consumer product, Tru Niagen® (nicotinamide riboside) is now available in all seven Whole...
ChromaDex Appoints Scripps Research Professor of Molecular Medicine, Brunie H. Felding, PhD, to the Scientific Advisory Board
July 23, 2019 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, July 23, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed Brunie H. Felding, Ph.D., Associate Professor, Department of Molecular Medicine, Scripps...
Newly Published Nicotinamide Riboside Study Further Demonstrates Safety of Sustained Niagen Supplementation and Optimal Dosing Levels
July 08, 2019 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, July 08, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that the results of its latest clinical study were published Friday in the journal Scientific Reports....
TRU NIAGEN® Awarded ‘Ingredient of the Year: Healthy Aging’ by NutraIngredients-USA
June 05, 2019 06:30 ET
|
ChromaDex Corporation
LOS ANGELES, June 05, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today its flagship consumer product, Tru Niagen® (nicotinamide riboside) received the ‘Ingredient of the Year:...